The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine

Background: Increased understanding of the molecular causes of disease has begun to fulfill the promise of precision medicine with the development of targeted drugs, particularly for serious diseases with unmet needs. The drug approval regulatory process is a critical component to the continued grow...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantor, Ariel, Haga, Susanne B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828670/
https://www.ncbi.nlm.nih.gov/pubmed/33466644
http://dx.doi.org/10.3390/jpm11010045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828670/
https://www.ncbi.nlm.nih.gov/pubmed/33466644
http://dx.doi.org/10.3390/jpm11010045

Ejemplares similares